LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
Halozyme Therapeutics
HALO
YETI Holdings
YETI
DexCom
DXCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 53.28%736.33M | -42.25%480.38M | ||||||||
Net income from continuing operations | ---- | ---- | ---- | -52.93%34.34M | ---- | ---- | ---- | ---- | -34.81%72.95M | ---- |
Operating gains losses | ---- | ---- | ---- | 28.52%-13.82M | ---- | ---- | ---- | ---- | -321.46%-19.33M | ---- |
Depreciation and amortization | ---- | ---- | ---- | -2.90%383.12M | ---- | ---- | ---- | ---- | -10.37%394.55M | ---- |
Deferred tax | ---- | ---- | ---- | -97.74%539K | ---- | ---- | ---- | ---- | -36.13%23.83M | ---- |
Change In working capital | ---- | ---- | ---- | 757.65%312.9M | ---- | ---- | ---- | ---- | -130.12%-47.58M | ---- |
-Change in receivables | ---- | ---- | ---- | 191.21%33.42M | ---- | ---- | ---- | ---- | 16.87%-36.64M | ---- |
-Change in inventory | ---- | ---- | ---- | 76.52%-3.91M | ---- | ---- | ---- | ---- | -28.93%-16.63M | ---- |
-Change in payables and accrued expense | ---- | ---- | ---- | 292.62%80.96M | ---- | ---- | ---- | ---- | -118.18%-42.03M | ---- |
-Change in other current assets | ---- | ---- | ---- | 155.49%1.59M | ---- | ---- | ---- | ---- | -48.30%-2.87M | ---- |
-Change in other current liabilities | ---- | ---- | ---- | 28.42%-54.98M | ---- | ---- | ---- | ---- | -49.66%-76.81M | ---- |
-Change in other working capital | ---- | ---- | ---- | 100.80%255.82M | ---- | ---- | ---- | ---- | 244.19%127.4M | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 2.64%183.6M | -9.58%165.31M | 4.96%157.65M | 53.28%736.33M | 64.01%224.43M | 39.47%178.88M | -6.14%182.82M | 632.41%150.2M | -42.25%480.38M | -5.54%136.84M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -378.50%-43.01M | -212.66%-75.44M | -118.27%-554K | 97.43%-23.23M | -108.88%-84.23M | 97.08%-8.99M | 115.50%66.96M | 102.43%3.03M | -29.54%-904.89M | 86.64%-40.33M |
Net PPE purchase and sale | -6.02%-89.57M | 36.11%-18.49M | 64.83%-35.56M | 45.22%-288.8M | 6.77%-74.27M | 52.19%-84.48M | 81.33%-28.94M | 12.70%-101.11M | 17.79%-527.23M | 75.51%-79.66M |
Net investment purchase and sale | -35.70%34.96M | -145.23%-51.98M | -45.97%45.59M | 175.54%261.41M | -64.66%7.73M | 160.84%54.37M | 142.55%114.93M | 1,097.23%84.38M | -4,322.11%-346.04M | -43.43%21.88M |
Net other investing changes | -45.08%11.6M | 73.92%-4.96M | -153.52%-10.58M | 113.15%4.16M | -201.44%-17.7M | 150.41%21.12M | -180.50%-19.03M | 5,207.49%19.77M | 51.64%-31.63M | 214.87%17.45M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -378.50%-43.01M | -212.66%-75.44M | -118.27%-554K | 97.43%-23.23M | -108.88%-84.23M | 97.08%-8.99M | 115.50%66.96M | 102.43%3.03M | -29.54%-904.89M | 86.64%-40.33M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 34.12%-104.75M | 38.97%-128.09M | 30.99%-125.39M | -348.18%-667.81M | -262.08%-117.25M | -229.79%-159M | -340.62%-209.87M | -298.06%-181.7M | 397.00%269.08M | -122.57%-32.38M |
Net issuance payments of debt | 18.79%-89.36M | -0.68%-114.64M | -35.10%-111.16M | -240.25%-377.92M | -123.10%-71.73M | -190.33%-110.04M | -229.35%-113.87M | -189.66%-82.28M | 397.72%269.45M | -122.23%-32.15M |
Net common stock issuance | 69.27%-15.05M | 85.99%-13.45M | 92.60%-7.3M | -9,878.09%-289.14M | -4,544,900.00%-45.45M | -3,490.86%-48.96M | ---96M | -6,620.87%-98.73M | -6.01%2.96M | ---1K |
Net other financing activities | ---336K | --0 | -900.00%-6.93M | 77.16%-760K | 70.74%-67K | --0 | --0 | 54.88%-693K | -2.68%-3.33M | 80.48%-229K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 34.12%-104.75M | 38.97%-128.09M | 30.99%-125.39M | -348.18%-667.81M | -262.08%-117.25M | -229.79%-159M | -340.62%-209.87M | -298.06%-181.7M | 397.00%269.08M | -122.57%-32.38M |
Net cash flow | ||||||||||
Beginning cash position | 23.88%141.76M | 141.50%179.98M | 43.98%148.28M | -60.15%102.98M | 222.60%125.33M | 19.11%114.43M | -69.71%74.52M | -60.15%102.98M | 19.79%258.42M | -85.71%38.85M |
Current changes in cash | 228.98%35.85M | -195.77%-38.22M | 211.39%31.7M | 129.14%45.29M | -64.22%22.95M | 119.04%10.9M | 126.62%39.91M | -129.15%-28.46M | -464.04%-155.44M | 578.26%64.13M |
End cash Position | 41.71%177.61M | 23.88%141.76M | 141.50%179.98M | 43.98%148.28M | 43.98%148.28M | 222.60%125.33M | 19.11%114.43M | -69.71%74.52M | -60.15%102.98M | -60.15%102.98M |
Free cash flow | -5.01%87.05M | -4.04%146.08M | 155.42%119.87M | 307.70%420.01M | 408.73%129.21M | 196.20%91.65M | 1,508.32%152.23M | 138.61%46.93M | -234.44%-202.22M | 112.55%25.4M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |